Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-25-020715

Director sold 22,000 shares at $3.40 ($74,800)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MOYES JAY M Director 2025-06-13 Sale 10b5-1 −22,000 $3.40 $74,800 53,322 D
Open-market sales · 22,000 sh · avg $3.40 · $74,800
Loading xslF345X05/rdgdoc.xml…